(EXPD) Expeditors International of - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3021301094
Stock: Airfreight, Ocean Freight, Customs Brokerage, Warehousing, Ground Transport
Total Rating 68
Risk 97
Buy Signal -0.07
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.22% |
| Yield on Cost 5y | 1.72% |
| Yield CAGR 5y | 7.34% |
| Payout Consistency | 95.7% |
| Payout Ratio | 34.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.0% |
| Relative Tail Risk | -8.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.43 |
| Alpha | 36.69 |
| Character TTM | |
|---|---|
| Beta | 0.746 |
| Beta Downside | 0.694 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.26% |
| CAGR/Max DD | 0.72 |
Description: EXPD Expeditors International of January 02, 2026
Expeditors International of Washington, Inc. (NASDAQ: EXPD) operates a global, asset-light logistics network spanning the Americas, North and South Asia, Europe, and the Middle East-Africa-India-Russia (MAIR) region. Its service suite includes air- and ocean-freight consolidation, customs brokerage, ground transportation, warehousing, temperature-controlled transit, cargo insurance, and trade-compliance consulting, serving customers in retail, electronics, healthcare, technology, and industrial manufacturing.
Key operating metrics from FY 2023 show revenue of approximately $10.2 billion and an adjusted operating margin near 12 %, reflecting the company’s efficient, low-capital model. The business is highly sensitive to macro-level freight-rate cycles and global trade volumes, with e-commerce growth and near-shoring trends acting as primary demand drivers. Recent Q1 2024 results beat consensus earnings, underscoring resilience amid ongoing supply-chain disruptions.
For a deeper quantitative view of EXPD’s valuation metrics, the ValueRay platform offers a concise, data-driven snapshot.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 845.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 7.88 > 1.0 |
| NWC/Revenue: 14.57% < 20% (prev 17.20%; Δ -2.64% < -1%) |
| CFO/TA 0.20 > 3% & CFO 972.9m > Net Income 845.5m |
| Net Debt (-629.8m) to EBITDA (1.18b): -0.53 < 3 |
| Current Ratio: 1.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (136.8m) vs 12m ago -3.00% < -2% |
| Gross Margin: 14.49% > 18% (prev 0.12%; Δ 1437 % > 0.5%) |
| Asset Turnover: 224.5% > 50% (prev 191.9%; Δ 32.55% > 0%) |
| Interest Coverage Ratio: -49.80 > 6 (EBITDA TTM 1.18b / Interest Expense TTM -22.5m) |
Altman Z'' 6.39
| A: 0.34 (Total Current Assets 3.67b - Total Current Liabilities 2.05b) / Total Assets 4.78b |
| B: 0.52 (Retained Earnings 2.47b / Total Assets 4.78b) |
| C: 0.23 (EBIT TTM 1.12b / Avg Total Assets 4.98b) |
| D: 0.91 (Book Value of Equity 2.28b / Total Liabilities 2.50b) |
| Altman-Z'' Score: 6.39 = AAA |
Beneish M -3.13
| DSRI: 0.83 (Receivables 2.05b/2.18b, Revenue 11.17b/9.92b) |
| GMI: 0.86 (GM 14.49% / 12.46%) |
| AQI: 1.16 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 1.13 (Revenue 11.17b / 9.92b) |
| TATA: -0.03 (NI 845.5m - CFO 972.9m) / TA 4.78b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of EXPD shares?
As of February 07, 2026, the stock is trading at USD 165.04 with a total of 1,326,126 shares traded.
Over the past week, the price has changed by +2.80%, over one month by +4.79%, over three months by +23.32% and over the past year by +50.88%.
Over the past week, the price has changed by +2.80%, over one month by +4.79%, over three months by +23.32% and over the past year by +50.88%.
Is EXPD a buy, sell or hold?
Expeditors International of has received a consensus analysts rating of 2.44.
Therefor, it is recommend to sell EXPD.
- StrongBuy: 0
- Buy: 0
- Hold: 10
- Sell: 3
- StrongSell: 3
What are the forecasts/targets for the EXPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 140.5 | -14.9% |
| Analysts Target Price | 140.5 | -14.9% |
| ValueRay Target Price | 189.7 | 14.9% |
EXPD Fundamental Data Overview February 07, 2026
P/E Trailing = 26.8933
P/E Forward = 27.4725
P/S = 1.9904
P/B = 9.6925
P/EG = 5.7475
Revenue TTM = 11.17b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.18b USD
Long Term Debt = 568.9m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 111.2m USD (from shortTermDebt, last quarter)
Debt = 560.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -629.8m USD (from netDebt column, last quarter)
Enterprise Value = 21.60b USD (22.23b + Debt 560.4m - CCE 1.19b)
Interest Coverage Ratio = -49.80 (Ebit TTM 1.12b / Interest Expense TTM -22.5m)
EV/FCF = 23.41x (Enterprise Value 21.60b / FCF TTM 922.7m)
FCF Yield = 4.27% (FCF TTM 922.7m / Enterprise Value 21.60b)
FCF Margin = 8.26% (FCF TTM 922.7m / Revenue TTM 11.17b)
Net Margin = 7.57% (Net Income TTM 845.5m / Revenue TTM 11.17b)
Gross Margin = 14.49% ((Revenue TTM 11.17b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 16.05% (prev 15.59%)
Tobins Q-Ratio = 4.52 (Enterprise Value 21.60b / Total Assets 4.78b)
Interest Expense / Debt = 0.03% (Interest Expense 159.0k / Debt 560.4m)
Taxrate = 25.19% (75.1m / 298.2m)
NOPAT = 840.0m (EBIT 1.12b * (1 - 25.19%))
Current Ratio = 1.79 (Total Current Assets 3.67b / Total Current Liabilities 2.05b)
Debt / Equity = 0.25 (Debt 560.4m / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = -0.53 (Net Debt -629.8m / EBITDA 1.18b)
Debt / FCF = -0.68 (Net Debt -629.8m / FCF TTM 922.7m)
Total Stockholder Equity = 2.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.99% (Net Income 845.5m / Total Assets 4.78b)
RoE = 37.64% (Net Income TTM 845.5m / Total Stockholder Equity 2.25b)
RoCE = 39.88% (EBIT 1.12b / Capital Employed (Equity 2.25b + L.T.Debt 568.9m))
RoIC = 37.59% (NOPAT 840.0m / Invested Capital 2.23b)
WACC = 8.45% (E(22.23b)/V(22.79b) * Re(8.66%) + D(560.4m)/V(22.79b) * Rd(0.03%) * (1-Tc(0.25)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.17%
[DCF Debug] Terminal Value 74.88% ; FCFF base≈790.0m ; Y1≈717.4m ; Y5≈626.5m
Fair Price DCF = 81.90 (EV 10.35b - Net Debt -629.8m = Equity 10.98b / Shares 134.0m; r=8.45% [WACC]; 5y FCF grow -11.42% → 2.90% )
EPS Correlation: -56.78 | EPS CAGR: -51.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: -63.89 | Revenue CAGR: -15.30% | SUE: 0.82 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.38 | Chg30d=+0.041 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=6.05 | Chg30d=+0.082 | Revisions Net=+4 | Growth EPS=+2.4% | Growth Revenue=-0.2%
P/E Forward = 27.4725
P/S = 1.9904
P/B = 9.6925
P/EG = 5.7475
Revenue TTM = 11.17b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.18b USD
Long Term Debt = 568.9m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 111.2m USD (from shortTermDebt, last quarter)
Debt = 560.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -629.8m USD (from netDebt column, last quarter)
Enterprise Value = 21.60b USD (22.23b + Debt 560.4m - CCE 1.19b)
Interest Coverage Ratio = -49.80 (Ebit TTM 1.12b / Interest Expense TTM -22.5m)
EV/FCF = 23.41x (Enterprise Value 21.60b / FCF TTM 922.7m)
FCF Yield = 4.27% (FCF TTM 922.7m / Enterprise Value 21.60b)
FCF Margin = 8.26% (FCF TTM 922.7m / Revenue TTM 11.17b)
Net Margin = 7.57% (Net Income TTM 845.5m / Revenue TTM 11.17b)
Gross Margin = 14.49% ((Revenue TTM 11.17b - Cost of Revenue TTM 9.55b) / Revenue TTM)
Gross Margin QoQ = 16.05% (prev 15.59%)
Tobins Q-Ratio = 4.52 (Enterprise Value 21.60b / Total Assets 4.78b)
Interest Expense / Debt = 0.03% (Interest Expense 159.0k / Debt 560.4m)
Taxrate = 25.19% (75.1m / 298.2m)
NOPAT = 840.0m (EBIT 1.12b * (1 - 25.19%))
Current Ratio = 1.79 (Total Current Assets 3.67b / Total Current Liabilities 2.05b)
Debt / Equity = 0.25 (Debt 560.4m / totalStockholderEquity, last quarter 2.28b)
Debt / EBITDA = -0.53 (Net Debt -629.8m / EBITDA 1.18b)
Debt / FCF = -0.68 (Net Debt -629.8m / FCF TTM 922.7m)
Total Stockholder Equity = 2.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.99% (Net Income 845.5m / Total Assets 4.78b)
RoE = 37.64% (Net Income TTM 845.5m / Total Stockholder Equity 2.25b)
RoCE = 39.88% (EBIT 1.12b / Capital Employed (Equity 2.25b + L.T.Debt 568.9m))
RoIC = 37.59% (NOPAT 840.0m / Invested Capital 2.23b)
WACC = 8.45% (E(22.23b)/V(22.79b) * Re(8.66%) + D(560.4m)/V(22.79b) * Rd(0.03%) * (1-Tc(0.25)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.17%
[DCF Debug] Terminal Value 74.88% ; FCFF base≈790.0m ; Y1≈717.4m ; Y5≈626.5m
Fair Price DCF = 81.90 (EV 10.35b - Net Debt -629.8m = Equity 10.98b / Shares 134.0m; r=8.45% [WACC]; 5y FCF grow -11.42% → 2.90% )
EPS Correlation: -56.78 | EPS CAGR: -51.84% | SUE: -4.0 | # QB: 0
Revenue Correlation: -63.89 | Revenue CAGR: -15.30% | SUE: 0.82 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.38 | Chg30d=+0.041 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=6.05 | Chg30d=+0.082 | Revisions Net=+4 | Growth EPS=+2.4% | Growth Revenue=-0.2%